Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. The Role of Receptor Activator of Nuclear Factor- B Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone Diseases
  1. Home
  2. Publications
  3. The Role of Receptor Activator of Nuclear Factor- B Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone Diseases

The Role of Receptor Activator of Nuclear Factor- B Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone Diseases

Author:
  • LHL. C. Hofbauer
    L. C. Hofbauer

Publisher website
Google Scholar
  • 1 July 2000
    • journal article
    • Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
    • Vol. 85  (7) , 2355-2363
    • DOI:10.1210/jc.85.7.2355
Abstract
No abstract available
Keywords
  • BONE DISEASES
  • METABOLIC BONE
  • TREATMENT
  • NUCLEAR FACTOR
  • RECEPTOR ACTIVATOR
  • ACTIVATOR OF NUCLEAR
  • ROLE OF RECEPTOR
  • LIGAND AND OSTEOPROTEGERIN
Cited by 53 articles
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.